**Core tip:** Bariatric surgery is increasingly and successfully applied for the treatment of morbid obesity. In spite of multiple clinical benefits, *i.e*., durable weight loss and improvement/reversal of many comorbidities, a number of nutritional complications can develop especially in the long term, which could cause serious detriment to patients' health. We examine some important clinical conditions that are caused by the deficit of vitamins and micronutrients, such as anemia, osteoporosis, and malnutrition. We also discuss the importance of careful pre-operative assessments and the correction of pre-existing nutritional deficiencies, and present the current recommendations for an appropriate biochemical and nutritional monitoring in the long term.

INTRODUCTION
============

Obesity has become an important public health priority because it increases the risk of comorbid conditions, including diabetes, cardiovascular disease and several types of cancers. In addition, it affects life quality and expectancy\[[@B1]\]. The impact of obesity on life expectancy has been well documented. Worldwide, over 2.5 million deaths annually can be attributed to obesity. Of particular concern is the growing economic burden that the care of obesity and its complications imposes on society and the health care system\[[@B2]\].

The increasing prevalence of obesity and comorbid conditions worldwide prompts for effective strategies for both treatment and prevention\[[@B1]\]. The treatment of obesity includes lifestyle changes (dietary restrictions and increased physical activity), the use of medications, and in some cases, surgery. Lifestyle changes can cause a 2%-6% weight loss; however, after 1-5 years, almost 90% of the patients have returned to their original weight or might even gain some weight. Drug treatment in general leads to a 5%-15% weight loss and should be considered only as an adjunct to lifestyle changes. Unfortunately, with respect to lifestyle intervention, medical treatment rarely yields satisfactory results in the long term\[[@B1],[@B3]\].

Bariatric surgery has proven to achieve greater weight loss than non-surgical management and, most importantly, has proven to maintain it in the long term\[[@B4]\]. Thus, in patients with morbid obesity, *i.e*., a body mass index of ≥ 40 or ≥ 35 kg/m^2^ with co-morbidities, bariatric surgery is presently considered to be the only effective therapy for obesity. Extensive data demonstrate that surgery can improve or even reverse many comorbidities, such as type 2 diabetes, hypertension, obstructive sleep apnea and steatohepatitis\[[@B5]-[@B7]\]. With regard to type 2 diabetes, observational and randomized controlled trials with a follow-up duration of up to 5 years have established the superiority of bariatric surgery over medical therapy at achieving remission of the disease and improvement of the overall cardiovascular risk profile\[[@B8]-[@B10]\]. One of the longest weight-loss studies - the Swedish Obese Subjects - evaluated the long-term effects of different bariatric procedures and demonstrated significant reductions in cardiovascular and cancer-related mortality as well as significant improvement in the quality of life\[[@B11]-[@B13]\].

In spite of multiple clinical benefits, a number of surgical and gastrointestinal complications can occur following bariatric procedures, although the diffusion of the laparoscopic approach and the expansion of centers of excellence have greatly reduced the rate of post-operative mortality and adverse events\[[@B14]\]. The mean mortality rate is 0.3% for all procedures, which is comparable to those for hip replacement (0.3%) or laparoscopic cholecystectomy (0.3%-0.6%). Indeed, even lower mortality rates (0.04-0.13) are achieved in high-volume obesity centers\[[@B14]\]. Among the possible complications, nutritional deficiencies deserve careful consideration. They can develop as a consequence of reduced intake and/or malabsorption of nutrients and are more commonly seen after malabsorptive or mixed procedures in comparison to the restrictive procedures. Other causal factors include pre-operative deficiencies, post-surgery food intolerance, changes in taste and eating patterns and non-adherence to dietary and supplement recommendations. Nutritional deficiencies can present with a wide range of clinical manifestations, depending on the specific nutrients/micronutrients that are involved, the severity, and the duration of the deficiency states. Because they could cause serious detriment to patients' everyday lives and, in some instances, could result in life-threatening complications, a nutritional screening both before and after surgery is strongly recommended.

This review focuses on the main nutritional issues related to bariatric procedures by examining some important clinical conditions that are caused by the deficit of vitamins and micronutrients, such as anemia, osteoporosis, neurologic disorders, and malnutrition. We will also discuss the importance of careful pre-operative assessments and the correction of pre-existing nutritional deficiencies, which are quite common in obese patients. Last, recommendations for the prevention and treatment of nutritional deficiencies after bariatric surgery are presented.

CONVENTIONAL BARIATRIC SURGICAL PROCEDURES
==========================================

Surgical procedures are generally classified into restrictive procedures, in which the stomach's capacity is greatly reduced, malabsorptive procedures, in which malabsorption is the primary driver of the weight loss, or a combination of restrictive and malabsorptive elements (Figure [1](#F1){ref-type="fig"}). However, over the past few years, it has become clear that weight loss is not only due to reduced food intake and/or absorption induced by modification of gastrointestinal anatomy but also a consequence of changes in neural and gut hormonal signals that regulate hunger and satiety, gut microbiota, intestinal nutrient sensing, food preferences, and possibly energy expenditure\[[@B15]\]. These so-called weight-independent mechanisms contribute to a variable extent to weight loss and metabolic improvement, depending on the type of surgical technique.

![Commonly performed bariatric surgeries. Modified from <http://www.bariatric-surgery-source.com/>.](WJD-8-464-g001){#F1}

***Laparoscopic adjustable gastric banding (AGB)***

An adjustable silicone band is placed around the upper stomach, a few centimeters below the cardia, creating a 15 to 30 mL gastric pouch. The diameter of the outlet can be changed by injection of or removal of saline through a portal placed in the subcutaneous tissue that is connected to the band.

***Roux-en-Y gastric bypass (RYGB)***

A small, vertically oriented gastric pouch is created, which remains attached to the esophagus at one end and, at the other end, is connected to a small section of the small intestine, thus bypassing the remaining stomach and the initial loop of the small intestine.

***Sleeve gastrectomy (SG)***

The operation involves division of the stomach vertically, which reduces its size by 75%. The pyloric valve at the bottom of the stomach is preserved such that the stomach function and digestion remain unaltered. The procedure is not reversible and might be a first stage procedure to a RYGB or duodenal switch.

***Biliopancreatic diversion (BPD)***

The operation consists of a distal horizontal gastrectomy that leaves a 200-250 mL of upper stomach. This remnant stomach is anastomosed to the distal 250 cm of small intestine (alimentary limb). The excluded small intestine (carrying bile and pancreatic secretion), called the biliopancreatic limb, is connected to the small bowel 50 cm proximal to the ileocecal valve. The 50-cm common limb is the only segment where digestive secretions and nutrients mix, which causes a marked malabsorption, especially for fat and protein.

A recent survey by the International Federation for the Surgery of Obesity showed that RYGB and SG account for the large majority of bariatric procedures (45% and 37%, respectively). The use of ABG has drastically fallen during the last decade and currently accounts for 10% of all procedures. BPD and its duodenal switch (BPD/DS)variant, which are truly malabsorptive procedures, are rarely used (\< 2%) to date given the high risk of nutritional complications\[[@B16]\].

NUTRITIONAL ISSUES AFTER BARIATRIC SURGERY
==========================================

Anemia
------

According to a recent report from the American Society of Hematology, people who have undergone bariatric procedures show the highest risk for anemia, with 33%-49% of operated patients presenting anemia within 2 years after surgery\[[@B17]\]. As expected, the average prevalence of anemia is lower following LSG (17%) and reaches 45%-50% after RYGB and BPD. It should be noted that, as underlined for other nutrient deficiencies, up to 10%-12% of obese patients already have anemia before surgery\[[@B18]\]; thus, baseline screening for anemia is recommended in all patients who are scheduled for bariatric procedures.

Patients with mild anemia are most likely asymptomatic; however, when the anemia worsens, the patients could present with symptoms, such as fatigue, pallor, and dyspnea on exertion. Of note, the presence of anemia increases by twofold the risk of hospitalizations as well as the length of the in-hospital stay\[[@B19]\].

Post-bariatric anemia is in most cases due to iron deficiency, along with vitamin B12 deficiency as a secondary cause. Iron deficiency, expressed by low serum ferritin, occurs in more than 30% of patients after 5 years from surgery, with a similar rate after RYGB and SG, as recently reported by Alexandrou et al\[[@B20]\]. Iron-deficiency can be attributed to several causes. Reduced iron absorption due to hypocloridria and the bypassing of the duodenum and proximal jejunum (which are the main sites of iron absorption) are the primary mechanisms that lead to iron deficiency. Post-operative reduction in food intake and changes in food preferences, such as intolerance for meat and dairy products, are important contributory factors.

Measurement of serum ferritin is the best diagnostic test for detecting iron deficiency since it is a more specific and earlier indicator of iron body capacity and becomes abnormal prior to a decrease in serum iron con-centration. For this reason, ferritin and hemoglobin should be periodically monitored in bariatric patients. Current guidelines\[[@B21]\] recommend oral iron supplementation in all operated patients for preventive purposes. However, for the correction of iron deficiency (when iron deficiency sets in), oral supplementation is not sufficient, and intravenous iron administration is required.

Vitamin B12 deficiency is a major cause of anemia in patients who undergo BPD and RYGB, with a prevalence of 19%-35% after 5 years\[[@B22]\]. Purely restrictive procedures are usually not associated with vitamin B12 deficiency. Vitamin B12 deficiency can result from inadequate secretion of intrinsic factor, limited gastric acidity and, above all, the bypassing of the duodenum, which is the main site of vitamin B12 absorption. Since the human body has substantial reserves of vitamin B12, clinical manifestations of a deficit can appear after a certain time from surgery, when the body stores are depleted to as little as 5%-10%. In addition to anemia, a lack of vitamin B12 can lead to neurological and psychiatric symptoms, including paresthesia, numbness, disturbance of coordination, memory disturbance and, in some instances, dementia. Oral or intramuscular supplementation of vitamin B12 is recommended after malabsorptive procedures, while there is no evidence of benefits after restrictive surgery.

Folic acid deficiency is a potential complication of bariatric procedures that can contribute to anemia. The prevalence of this deficit after both restrictive and malabsorptive procedures ranges from 9% to 39%\[[@B23],[@B24]\]. It can manifest as macrocytic anemia, piastrinopenia, leucopenia, or glossitis. It could cause growth retardation and, in pregnant women, congenital defects (neural tube). Since folate is absorbed throughout the small intestine, the deficiency is primarily induced by a shortage of dietary intake rather than malabsorption. Furthermore, folate deficiency can be aggravated by vitamin B12 deficiency since the latter is necessary for the conversion of inactive methyltetrahydrofolic acid to the active tetrahydrofolic acid. Folate deficiency can be easily corrected by oral supplementation.

Abnormalities of bone metabolism
--------------------------------

Bariatric surgery could impact bone metabolism and induce significant changes, such as decreased mechanical loading, calcium/vitamin D malabsorption with secondary hyperparathyroidism, nutritional deprivations, changes in fat mass and alterations in fat- and gut-derived hormones\[[@B25]-[@B27]\].

In general, weight loss, achieved through dietary restriction, drugs or bariatric surgery, is associated with a significant reduction in bone mineral density (BMD) and increased bone turnover\[[@B28]\]. In particular, the bone loss reported after non-surgical weight loss is much lower (1%-2%)\[[@B29]\] than that found after bariatric procedures (8%-13%)\[[@B30],[@B31]\] A recent meta-analysis of studies that compare bariatric vs a non-operated control group showed reduced BMD at the femoral neck but not at the lumbar spine\[[@B30]\]. However, it is important to note that the measurement error at the spine BMD is greater than at other sites, which could likely account for this discrepancy. In addition, there is high heterogeneity in the studies analyzed with regard to different surgery procedures, study design (most retrospective), and patient characteristics (ethnicity, sex, menopausal/postmenopausal stage, follow-up length), which could account for the differences between the two sites. Overall, the reductions in the BMD results are greater after malabsorptive or mixed than after restrictive procedures. Studies that compare RYGB and SG have shown a greater bone loss after RYBG than SG, especially at the hip and femoral neck\[[@B32]\]. Accordingly, bone turnover expressed by circulating markers such as CTX, PINP, TRAcP5b was significantly higher after RYGB than after SG\[[@B33]\]. The difference in the BMD between the two procedures could also be related to the different hormonal patterns induced by the two operations. Indeed, there is increasing evidence that many fat- and gut-derived hormones could affect bone health\[[@B25],[@B33],[@B34]\]. In particular, low levels of GIP, ghrelin, amylin, and insulin and high levels of PYY exert negative effects on the bone mass. In contrast, low serotonin and high GLP-1 levels appear to positively influence the bone metabolism\[[@B25]\]. However, further studies are needed to better define the role of these hormones in the regulation of bone metabolism.

Bariatric surgery is associated with an increased risk of fractures\[[@B35],[@B36]\]. In a population-based study, the cumulative incidence of any new fracture at 15 years was 58% in bariatric patients compared to 24% in non-operated men and women of similar age. The relative risk for any fracture was increased by 2.3-fold both at the traditional osteoporotic (hip, spine, wrist) and at non-osteoporotic sites\[[@B35]\].

Calcium and vitamin D deficiencies are the main factors that are responsible for the accelerated bone loss after bariatric surgery. The incidence of calcium deficiency after surgery is almost 10%\[[@B37]\] and is caused by reduced calcium absorption that results from bypassing the duodenum and proximal jejunum, which are the main sites of absorption. In some cases, calcium deficiency could be exacerbated by low calcium intake due to the intolerance/exclusion of milk products.

The prevalence of hypovitaminosis D after surgery varies between 25% and 73%, depending on the duration of the follow-up and its defining parameters (25-OH-vitamin D \< 20 or \< 30 ng/mL). It is important to note that hypovitaminosis D exists in a large proportion of patients prior to surgery, with reports that range from 25% to 80%. However, bariatric surgery *per se* affects the vitamin D status\[[@B38]\]. Indeed, similar to calcium deficiency, hypovitaminosis D could be a consequence of fat malabsorption, due to the bypass of the primary absorption sites of liposoluble vitamins in the small intestine\[[@B39],[@B40]\]. In fact, a duodenal surgical bypass decreases cholecystokinin secretion, which results in a reduction in pancreatic lipolytic enzyme secretions and alteration in biliary salts, which in turn leads to an alteration in fat digestion and steatorrhea\[[@B24]\]. In addition, after both malabsorptive and restrictive procedures, reduced intake of dairy products, vomiting, and non-adherence to supplement recommendations could worsen the vitamin D status\[[@B39],[@B40]\].

These are no clear recommendations for vitamin D doses following bariatric surgery, since individual patients could require larger or smaller doses according to the degree of deficit. Current recommendations\[[@B21]\] indicate that at least 5000 IU/d is required to maintain adequate vitamin D levels after RYGB, while higher doses (up to 50000 IU) are required after BPD. Recent studies have suggested that the vitamin D level should be maintained at over 25-30 ng/mL for the effective prevention of osteoporosis and fracture risk. Daily calcium supplementation (preferably as calcium citrate) from 1200 to 2000 mg daily is recommended. It must be considered that oral calcium could interfere with the absorption of some essential minerals such as iron, zinc and copper.

Deficiencies of other vitamins and minerals
-------------------------------------------

Low serum levels of fat-soluble vitamins (vitamin A, K and E) have been found to occur after malabsorptive procedures (BPD and long limb RYGB). However, the available data are largely based on clinical reports and, therefore, are insufficient to estimate the real prevalence of these deficiencies. In two series of studies, the incidence of vitamin A deficiency was 61%-69% at 2-4 year after BPD, with or without duodenal switch\[[@B41],[@B42]\]. In a third series, the incidence was as low as 5% by 4 year\[[@B43]\]. Clinical manifestation of vitamin A deficits are night blindness, xerophthalmia and dry hair.

Low levels of vitamin K have been reported in 50%-60%\[[@B42]\] of patients who underwent BPD or BPD/DS, but no clinical symptoms such as easy bruising, increased bleeding, or clotting alterations were reported.

With regard to the water-soluble vitamins, thiamine (vitamin B1) deficiency can occur in up to 49% of patients after surgery as a result of bypass of the jejunum, where it is primarily absorbed, or in the presence of impaired nutritional intake from persistent, severe vomiting\[[@B44]\]. The early symptoms of thiamine deficiency are nausea and constipation, followed by neurological and psychiatric complications known as Wernicke-Korsakoff syndrome. The prevalence of vitamin C deficiency ranges from 10%-50%\[[@B45],[@B46]\], but it rarely results in manifest clinical signs (poor wound healing, petechiae, bleeding gums).

Although most of the literature focuses on calcium and iron, deficiencies of other essential minerals such as magnesium, zinc, copper, and selenium have been reported in bariatric patients\[[@B47]\]. Essential minerals act as enzymatic cofactors in several biochemical pathways, and therefore, their deficiency could cause variable clinical manifestations that involve neurological, cardiac and gastrointestinal systems. Mineral deficiencies are more common after BPD and RYGB; however, the real prevalence of these disturbances cannot be precisely estimated since most deficiencies can be present already before surgery (see the next paragraph). In addition, for some minerals such as copper and magnesium, the circulating concentrations might not reflect their total body stores, thus leading to underestimation of the real deficit.

Protein malnutrition
--------------------

Protein malnutrition remains the most severe macronutrient complication associated with malabsorptive surgical procedures. It has been reported in 7%-21% of patients who underwent BPD and is a consequence of poor protein digestion and absorption secondary to altered biliary and pancreatic function\[[@B48]\]. Protein malnutrition can also occur after RYGB, where the Roux limb exceeds 150 cm, with an incidence of 13% at the 2-year follow-up. SG and AGB can lead to protein malnutrition in patients who present maladaptive eating behaviors after surgery, those who avoid protein food sources and those who have protracted vomiting. The clinical signs of protein malnutrition include edema, hearing loss and low serum albumin level (\< 3.5 g/dL). Protein malnutrition associated with malabsorptive procedures causes an annual hospitalization rate of 1% per year and leads to significant morbidity and poor outcomes\[[@B49],[@B50]\]. Monitoring the serum albumin concentration is useful for the evaluation of the protein nutritional state, although the serum protein level often remains in the normal range until late. Measurement of lean body mass by means of dual X--ray absorptiometry or body bioimpedence assessment can be helpful for the evaluation of body composition, although their accuracy appears to be limited in bariatric patients.

According to consensus guidelines\[[@B21]\], the prevention of protein malnutrition requires an average daily protein intake of 60-120 g (1.1 g/kg of ideal body weight), which should be increased by 30% following BPD. Furthermore, great emphasis is posed on regular training and aerobic exercise as being essential to preserving lean mass and especially muscle mass. Patients with severe protein malnutrition should be managed with modular protein supplements that are rich in branch-chain amino acids and, eventually, enteral feeding.

Post-operative weight regain
----------------------------

The regain of the weight lost is one of the main concerns of bariatric patients over the long term. The incidence of this phenomenon is quite variable according to the type of procedure performed, the length of follow-up and, above all, the criteria to define weight regain. Among different definitions, the most widely accepted method refers to a regain of 25%-30% of the maximum weight lost, corresponding to the weight before surgery, with the subtraction of minimum weight or "nadir" after surgery\[[@B51]-[@B53]\]. A recent review has shown that the rates of weight regain for SG range from 5.7% at 2 years to 75.6% at 6 years\[[@B54]\]. For RYGB, the percentage of failure to maintain weight loss varies from 7% to 50% of the subjects and tends to be higher in superobese patients\[[@B55]\]. AGB is associated with the largest weight regain (35%-40% of the weight lost), as evidenced in several clinical studies\[[@B11],[@B51]\].

The failure to maintain long-term weight loss has important consequences on the patients' health, including the relapse of obesity-related co-morbidities\[[@B56]\]. Furthermore, it has substantial economic repercussions for the recurrent costs associated with the management of on-going obesity. Therefore, there have been many efforts to understand the biological and psychologic/behavioral bases that underlie this important phenomenon.

One of the major factors responsible for weight regain is the reduction in energy expenditure (EE), which is generally paralleled by the simultaneous loss of lean body mass\[[@B57]\]. Recently, Tam et al.\[[@B57]\] showed that EE is significantly reduced 1 year after RYGB (-124 ± 42 kcal/die) as well as after SG (-155 ± 118 kcal/die) compared to the baseline. These findings extend what was already known with diet-induced weight loss and give support to the view that the reduction in EE is a homeostatic mechanism that counteracts a reduction in the caloric intake, which is aimed at preventing excessive weight loss; however, in some conditions, it could favor weight regain.

Another factor that contributes to weight regain is the changes in entero-hormone and appetite regulation\[[@B56]\]. As widely demonstrated, BS is associated with a recovery of the postprandial response of GLP-1, which increases by 3- to 6-fold compared to pre-surgery levels\[[@B58]\]. Interestingly, it has been shown\[[@B52]\] that in patients operated by RYGB, the post-meal response of GLP1 was significantly greater in individuals who maintained weight loss compared to individuals who failed, which suggests that this hormone plays a role in the maintenance of a favorable weight outcome. With regard to ghrelin, the results are quite controversial, with some but not all\[[@B59]\] studies showing greater and more sustained suppression of ghrelin levels in bariatric patients who maintained appropriate weight loss compared to those who regained weight\[[@B60],[@B61]\].

Moreover, mental health disorders, such as depression, alcohol and drug use, and food urges are predictive factors of weight regain\[[@B62],[@B63]\]. Although binge eating is more frequent among obese patients who make recourse to BS (10%-50%), there is no doubt that its persistence after surgery is associated with a minor weight loss and an early weight regain\[[@B64]\].

Beyond all of the above-mentioned factors, the success of bariatric surgery is strongly influenced by the patients' motivation to adhere to a healthier lifestyle, including controlled energy intake and physical activity\[[@B65]\]. In the Swedish Obese Subjects study\[[@B66]\], the reported mean energy intake was 2900 kcal/die before surgery, 1500 kcal/die 6 mo after surgery and approximately 2000 kcal/die 4-10 years after surgery, which demonstrates a progressive increase in calorie intake over the years. These data emphasize dietary counselling and the practice of physical exercise as fundamental measures to prevent weight recidivism.

PRE-OPERATIVE NUTRITIONAL STATE: A CRITICAL FACTOR
==================================================

It is a common belief that nutritional deficiencies are rare in Western countries due to the availability of low cost and unlimited variety of food supply. However, obese subjects often adopt an unhealthy diet that is rich in high-calorie food with an unbalanced nutritional composition\[[@B67],[@B68]\]. The concomitant presence of high calorie intake and nutrient deficiencies could impact the effectiveness of calorie utilization, which could determine a vicious cycle that leads to further weight gain, depression, eating disorders, metabolic syndrome, fatigue and more\[[@B67]\]. In support of these concepts, a growing number of studies in the literature attest to the frequent occurrence of nutrient and/or vitamin/mineral deficiencies in morbidly obese individuals prior to bariatric surgery, before weight loss and possible surgical-related malabsorption set in.

With regard to the vitamin status, most evidence refers to a 25(OH)vitamin D deficit. Vitamin D insufficiency (\< 30 ng/dL) has been reported in approximately 90% of different study populations, and ranges from 65%\[[@B69]\] to 100%\[[@B70]\], while vitamin D deficiency (\< 20 ng/dL) is observed in approximately 60% of the patients, ranging from 22%\[[@B71]\] to 83%\[[@B72]\]. The prevalence of severe deficit (\< 10 ng/dL) could reach 25%\[[@B73]\]. The degree of deficiency is predicted by the degree of obesity and race, with African Americans being at higher risk\[[@B74]\].

Obese individuals are more likely to be deficient in vitamin D because of the higher volumetric dilution and sequestration of this fat-soluble hormone in the adipose tissue\[[@B75]\]. As the fat mass increases, an individual will require greater amounts of vitamin D (*via* photoproduction from sun exposure, dietary intake, and/or supplementation). Moreover, although there is no difference in the vitamin D~3~ production between obese and lean individuals, obese patients show an impaired release of vitamin D~3~ from the skin\[[@B76]\]. Genetic variation in the function of the vitamin D binding protein and vitamin D receptor could also influence the 25(OH)D levels, with some studies suggesting a higher frequency of the poorer functioning forms in obesity\[[@B77],[@B78]\].

The prevalence of vitamin B12 deficiency in patients scheduled for BS is reported in approximately 18% of patients. Similarly, low levels of vitamin B1 (thiamine) are reported in up to 20% of bariatric candidates. Few studies have assessed the vitamin C status in bariatric candidates, with a prevalence that ranges from 15%\[[@B69]\] to 33%\[[@B79]\]. With regard to vitamins A and E, their deficiencies are less frequent\[[@B69],[@B73]\]. In particular, vitamin A has been found to be inversely associated with BMI, age and number of comorbidities\[[@B73]\]. This finding most likely occurs because low vitamin A levels are related to increased oxidative stress, insulin resistance, impaired glucose metabolism, cancers, and age-related macular degeneration\[[@B80]\], all of which are commonly associated with morbid obesity.

Among the minerals, iron deficiency is the most common and ranges from 20% to 47%\[[@B81]\]. Iron and ferritin deficiency and iron-deficiency anemia are more frequent in younger patients (\< 25 years) than in older patients and in women than in men, although this finding is not confirmed in all studies\[[@B82]\]. Iron deficiency in obese patients is likely related to the negative impact that chronic inflammation exerts on iron homeostasis. In particular, there is evidence that cytokines (TNFα and IFNγ) can induce the apoptosis of erythroid progenitor cells and increase hepcidin levels, which leads in turn, to reduced intestinal iron absorption and reduced bioavailability\[[@B83]\].

The prevalence of zinc deficiency prior to bariatric surgery amounts to 10.2%\[[@B84]-[@B86]\]. Interestingly, some studies have shown an inverse association of zinc levels, with C-reactive protein highlighting the adverse influence of systemic low-grade inflammation on the zinc status\[[@B84]\].

Overall, the high prevalence of pre-surgery nutritional deficiencies in bariatric candidates supports the need for a careful pre-operative evaluation of the nutritional status, to assess and adequately correct the pre-existing deficits.

CONCLUSION
==========

Nutritional deficiencies represent a relevant long-term clinical problem in patients who underwent bariatric surgery as a result of modifications to the gastrointestinal anatomy and physiology, which could impact macro- and micro-nutrient absorption. Therefore, the best practices guidelines\[[@B21]\] highly recommend regular metabolic and nutritional monitoring after bariatric surgery, which frequency varies according to the type of procedure. In light of the high prevalence of nutrient deficiencies even prior to surgery, the current Guidelines also underscore the need for a complete pre-surgery nutritional assessment in all candidates for bariatric surgery. The schedule of the biochemical and nutritional monitoring for the different procedures is reported in Table [1](#T1){ref-type="table"}. Although there are few studies with long-term nutritional follow-up, there is general agreement that nutritional assessments should be performed throughout life; furthermore, multivitamin and calcium supplementation with added vitamin D is recommended for all weight-loss surgery patients. In conclusion, nutritional surveillance is an essential component of the management of bariatric patients for the following reasons: (1) increases the patients' adherence to healthy dietary habits and appropriate supplementation regimens; (2) prevents the risk of weight regain; (3) facilitates the detection of possible nutritional deficiencies that could develop despite medical therapy; and (4) contributes to maintaining a good quality of life.

###### 

Schedule of biochemical and nutritional assessments for the different bariatric procedures

  Assessments    Pre-operative                                        1 mo                                                 3 mo                                                 6 mo                                                 12 mo                                                18 mo                                                24 mo                                                Annually
  -------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  MOC DEXA                                                                                                                                                                                                                                                                                                                                     AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB3, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}
  Calcium        AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}
  Magnesium      AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                                 RYGB, BPD[1](#T1FN1){ref-type="table-fn"}            RYGB, BPD[1](#T1FN1){ref-type="table-fn"}
  Phosphorus     AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                                                                                                                                  AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}
  Zinc           AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        RYGB, BPD[1](#T1FN1){ref-type="table-fn"}            RYGB, BPD[2](#T1FN2){ref-type="table-fn"}            AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}
  Iron           AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        RYGB, BPD[1](#T1FN1){ref-type="table-fn"}            RYGB, BPD[1](#T1FN1){ref-type="table-fn"}            AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   RYGB, BPD[1](#T1FN1){ref-type="table-fn"}            AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}
  Transferrin    AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}
  Ferritin       AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}
  Vitamin A      AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        RYGB, BPD[1](#T1FN1){ref-type="table-fn"}            RYGB, BPD[1](#T1FN1){ref-type="table-fn"}            RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                                 RYGB, BPD[1](#T1FN1){ref-type="table-fn"}            RYGB, BPD[1](#T1FN1){ref-type="table-fn"}
  Vitamin E      AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                                                                                                                                  AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                                                                             
  Vitamin D      AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        RYGB, BPD[2](#T1FN2){ref-type="table-fn"}            RYGB, BPD[2](#T1FN2){ref-type="table-fn"}            AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}
  Vitamin B1     AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}   AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}
  Vitamin B6     AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                                                                                                                                  AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                                                                             AGB[3](#T1FN3){ref-type="table-fn"}, SG[3](#T1FN3){ref-type="table-fn"}, RYGB[3](#T1FN3){ref-type="table-fn"}, BPD[1](#T1FN1){ref-type="table-fn"}, [3](#T1FN3){ref-type="table-fn"}
  Vitamin B12    AGB, SG, RYGB, BPD[1](#T1FN1){ref-type="table-fn"}                                                                                                             AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}
  Parathormone   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                                                                             AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}                                                        AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}   AGB, SG, RYGB, BPD[2](#T1FN2){ref-type="table-fn"}

Useful, including all contents in the space;

Recommended, including all contents in the space;

Every 2-5 years. AGB: Laparoscopic adjustable gastric banding; SG: Sleeve gastrectomy; RYGB: Roux-en-Y gastric bypass; BPD: Biliopancreatic diversion.
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